Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
361 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Closed (1)

Medical Condition

  • Show all (122)
  • Autoimmune Disorders (1)
  • Bone & Muscle (1)
  • Cancer (6)
    • Leukemia (3)
    • (-) Lymphoma (1)
    • Solid Tumors (1)
  • COVID-19 (Coronavirus) (1)
  • Diabetes (1)
  • Gastrointestinal and Digestive Diseases (3)
  • Healthy Volunteers (3)
  • Liver Disease (1)
  • Lung Disease (1)
  • Pediatrics (97)
  • Psychiatric Disorders (1)
  • Transplant (6)
Displaying 1 - 1 of 1

Study of Ibrutinib in Pediatric and Young Adult Patients With Relapsed or Refractory Mature B-cell non-Hodgkin Lymphoma (Ages 1-30)

Condition: Cancer / Lymphoma
Investigator: Nobuko Hijiya, MD
Status: Closed
This is a 2-part, multicenter study of a study drug in pediatric and young adult patients with mature B-cell non-Hodgkin Lymphoma which has come back or has not responded to the standard therapy. The study treatment is considered an experimental because the study drug is not approved by the United States (US) Food and Drug Administration (FDA) for treating…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Contact RecruitMe Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science